Drug Type Small molecule drug |
Synonyms 3-(5'-Nitrofurfuralamino)-2-oxazolidone, 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone, 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone + [9] |
Target |
Mechanism DNA inhibitors(DNA inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (20 Jan 1958), |
Regulation- |
Molecular FormulaC8H7N3O5 |
InChIKeyPLHJDBGFXBMTGZ-UHFFFAOYSA-N |
CAS Registry67-45-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00830 | Furazolidone |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cholera | CN | 01 Jan 1981 | |
Dysentery | CN | 01 Jan 1981 | |
Giardiasis | CN | 01 Jan 1981 | |
Trichomonas Infections | CN | 01 Jan 1981 | |
Typhoid Fever | CN | 01 Jan 1981 | |
Enteritis | US | 20 Jan 1958 |
Not Applicable | Helicobacter pylori infection Second line | 176 | Triple therapy | fibljigxvc(mbrirwcqti) = xuowfbmcux myezlvkmlo (efhmpodyvg ) | - | 01 Sep 2009 | |
fibljigxvc(mbrirwcqti) = wbsjjbgjji myezlvkmlo (efhmpodyvg ) |